Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 2/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22352965 | 1.00 | SLC9A1 (0.48) | SLC9A1IDO1ALDH1A1ATMMAPK1 | |
| SCHEMBL30805855 | 0.82 | SLC6A4 (0.57) | SLC9A1IDO1ALDH1A1ATMMAPK1 | |
| SCHEMBL29302528 | 0.82 | SLC9A1 (0.58) | SLC9A1ALDH1A1TSHRSLC6A4SLC6A3 | |
| SCHEMBL4717140 | 0.82 | SLC6A4 (0.57) | SLC9A1IDO1ALDH1A1ATMMAPK1 | |
| SCHEMBL5752833 | 0.82 | SLC9A1 (0.58) | SLC9A1ALDH1A1TSHRSLC6A4SLC6A3 | |
| SCHEMBL30715031 | 0.82 | SLC9A1 (0.58) | SLC9A1ALDH1A1TSHRSLC6A4SLC6A3 | |
| SCHEMBL4717135 | 0.82 | SLC6A4 (0.57) | SLC9A1IDO1ALDH1A1ATMMAPK1 | |
| SCHEMBL3031608 | 0.82 | SLC9A1 (0.45) | SLC9A1IDO1ALDH1A1ATMSLC6A4 | |
| SCHEMBL25602859 | 0.82 | SLC6A4 (0.57) | SLC9A1IDO1ALDH1A1ATMMAPK1 | |
| SCHEMBL5752830 | 0.82 | SLC9A1 (0.58) | SLC9A1ALDH1A1TSHRSLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199624-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | CHDI FOUNDATION INC (US) | 2024-06-20 | — | — | US | disclosed |
| WO-2024118607-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | CHDI FOUNDATION, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199624-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | MSH2, KRAS, CHAMP1 | SLC9A1 2775/4885IDO1 3263/4885ALDH1A1 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.